RxDoctor Payments Data

Alexandra Lelchuk, MD

Interventional Pain Medicine · Kenosha, WINPI 1336594910

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (54.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 80.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $5,091 and has fallen 98.4% since, to $81 in 2025.

$9,259in general payments, 2019–2025

Across 52 payments — averaging $178.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Abbott$756
  • Boston Scientific$704
  • SPR Therapeutics, Inc$275
  • Baudax Bio Inc.$64
  • Pacira Pharmaceuticals Incorporated$31

What the payments were for

  • Grants$5,00054%
  • Travel & lodging$1,41915%
  • Food & beverage$2,83931%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,259 in reported general payments places this provider in the 75th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$59,942
Medicare patients
140
Services billed
806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SavellaMilnacipran Hcl11$10,900
Lidocaine31$2,701
Gabapentin158$2,562
Pregabalin84$1,401
Baclofen134$1,332
Diclofenac Sodium11$1,115
Cyclobenzaprine Hcl82$609
Tizanidine Hcl73$378
Duloxetine Hcl39$255
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$207
Meloxicam38$98
Methylprednisolone16$79
Tramadol Hcl13$23
Alprazolam25$15

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →